HOME > TOP STORIES
TOP STORIES
-
REGULATORY New Health Minister Vows to Put Public Needs First in 2024 Drug Pricing Reform
September 15, 2023
-
REGULATORY Japan to Basically Drop Japanese PI Requirement before Global Clinical Trials
September 14, 2023
-
REGULATORY Chuikyo Mixed on Expanding Range of CEA Price Adjustments for Pricey Meds
September 14, 2023
-
REGULATORY Keizo Takemi Tapped as New Health Minister in Cabinet Reshuffle
September 14, 2023
-
REGULATORY Japan’s Envisaged IP Tax Relief Likely to Cover Drug Sales, METI Eyes FY2024 Rollout
September 13, 2023
-
REGULATORY Moderna’s Omicron XBB.1.5 Vaccine Snags Japan Approval
September 12, 2023
-
REGULATORY New MHLW Drug Review Chief Vows to Make Japan Attractive Place for Clinical Trials, Watching Debate on Japanese PI
September 12, 2023
-
BUSINESS Sumitomo to Ramp Up Regenerative, Cell Therapy Biz to Counter Latuda Patent Cliff
September 11, 2023
-
BUSINESS After Idorsia Deal, Sosei Pivoting to High-Profit Model with In-House Sales System
September 8, 2023
-
BUSINESS Astellas Drops IRA Lawsuit after Xtandi Avoids 1st Drug List
September 8, 2023
-
ORGANIZATION Single-Wholesaler Model Has No Merits for Hospitals: Hyogo Doctors Group
September 7, 2023
-
REGULATORY Japan Eyes AI-Driven Drug Discovery Project for Cancer, Intractable Diseases
September 7, 2023
-
BUSINESS Osaka Court Bars Sawai’s Teribone Generic over Manufacturing Patents
September 6, 2023
-
BUSINESS Santen to Run Voluntary Redundancy Program Targeting Age 50 and Up
September 5, 2023
-
REGULATORY Japan Approves Pfizer’s Omicron XBB.1.5 Vaccine, Moderna’s Still under Review
September 4, 2023
-
REGULATORY MHLW Must Streamline Operations via DX, Improve Staff’s Work-Life Balance: Official
September 1, 2023
-
REGULATORY Chuikyo Payer Rep Floats Deferred Price Cuts for PMP upon Generic Entries
August 31, 2023
-
BUSINESS Novartis Rolls Out Luxturna in Japan, 2 Treatment Facilities Selected
August 31, 2023
-
REGULATORY MHLW Top Pharma Officer Remains Committed to Fast, Safe Access to Good Drugs
August 31, 2023
-
REGULATORY Medical DX Office to Kick Off in September, Explore Better Use of Medical Data for Drug Discovery
August 30, 2023
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
